SCHEMBL30457930

SCHEMBL30457930

O=C(O)CCCCCCC/C=C\CCCCCCCCCCCCCCCCCCC(O)CCCCCCCCCCCCCC/C=C\CCCCCCCC(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 2/20 0.71
▸ FFAR4 Q5NUL3 2/20 0.71
▸ PPARG P37231 4/20 0.60
▸ TERT O14746 3/20 0.60
▸ PTPN1 P18031 3/20 0.60
▸ PPARD Q03181 3/20 0.60
▸ PPARA Q07869 3/20 0.60
▸ MAPT P10636 2/20 0.60
▸ BLM P54132 2/20 0.60
▸ HSD17B10 Q99714 2/20 0.60
▸ FABP4 P15090 2/20 0.60
▸ F7 P08709 2/20 0.60
▸ F3 P13726 2/20 0.60
▸ GMNN O75496 1/20 0.60
▸ USP2 O75604 1/20 0.60
▸ LMNA P02545 1/20 0.60
▸ CYP1A2 P05177 1/20 0.60
▸ POLB P06746 1/20 0.60
▸ CYP2C9 P11712 1/20 0.60
▸ ALOX15 P16050 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17128751 1.00 FFAR1 (0.71) FFAR1FFAR4PPARGTERTPTPN1
SCHEMBL10081556 1.00 FFAR1 (0.71) FFAR1FFAR4PPARGTERTPTPN1
SCHEMBL30457666 1.00 FFAR1 (0.71) FFAR1FFAR4PPARGTERTPTPN1
SCHEMBL30458046 1.00 FFAR1 (0.71) FFAR1FFAR4PPARGTERTPTPN1
SCHEMBL30458023 1.00 FFAR1 (0.71) FFAR1FFAR4PPARGTERTPTPN1
SCHEMBL3022861 0.98 FFAR1 (0.69) FFAR1FFAR4PPARGTERTPTPN1
SCHEMBL30951731 0.94 FFAR1 (0.65) FFAR1FFAR4PPARGPPARDPPARA
Oleic Acid SCHEMBL6462631 0.91 FFAR1 (0.85) FFAR1FFAR4PPARGTERTPTPN1
SCHEMBL1301435 0.91 FFAR1 (0.75) FFAR1FFAR4PPARGTERTPTPN1
SCHEMBL1301331 0.91 FFAR1 (0.75) FFAR1FFAR4PPARGTERTPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4452934-A1 IONIZABLE DISULFIDE LIPIDS AND LIPID NANOPARTICLES DERIVED THEREFROM Providence Therapeutics Holdings Inc. (CA) 2024-10-30 — — EP disclosed
WO-2023115221-A1 IONIZABLE DILSULFIDE LIPIDS AND LIPID NANOPARTICLES DERIVED THEREFROM PROVIDENCE THERAPEUTICS HOLDINGS INC. (CA) 2023-06-29 — — WO disclosed
Send feedback